Australia’s medical cannabis market has adopted a California-style approach to the drug, Althea chief executive Josh […]
Althea CEO says TGA negligence and competitor misconduct drove medical cannabis division's decline
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
cannabis-infused drinks
gummies
JOsh Fegan
NWR Virtual Healthcare Conference
pastilles
Peak Processing
THC beverages
Related Articles
